Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy
Open Access
- 12 June 2008
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 22 (9), 1721-1727
- https://doi.org/10.1038/leu.2008.161
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignanciesBlood, 2008
- High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide–driven graft-versus-leukemia effectsBlood, 2007
- Translational Mini-Review Series on Vaccines:
Peptide vaccines for myeloid leukaemiasClinical and Experimental Immunology, 2007
- Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid LeukemiaNew England Journal of Medicine, 2006
- Impact of Donor and Recipient Sex and Parity on Outcomes of HLA-Identical Sibling Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2006
- Detection and Functional Analysis of CD8+ T Cells Specific for PRAME: a Target for T-Cell TherapyClinical Cancer Research, 2006
- Identification and in vitro expansion of CD4+ and CD8+ T cells specific for human neutrophil elastaseBlood, 2004
- CD7 expression by CD34+ cells in CML patients, of prognostic significance?European Journal of Haematology, 2003
- The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemiaBlood, 2003
- Allogeneic stem cell transplantation for chronic myeloid leukemiaSeminars in Hematology, 2003